NorthCoast Asset Management LLC lifted its holdings in shares of Amedisys Inc (NASDAQ:AMED) by 250.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 16,420 shares of the health services provider’s stock after acquiring an additional 11,736 shares during the quarter. NorthCoast Asset Management LLC’s holdings in Amedisys were worth $865,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of AMED. Quantitative Systematic Strategies LLC acquired a new position in shares of Amedisys during the third quarter worth $205,000. Amalgamated Bank acquired a new position in shares of Amedisys during the second quarter worth $246,000. Fox Run Management L.L.C. acquired a new position in shares of Amedisys during the fourth quarter worth $269,000. Janus Henderson Group PLC acquired a new position in shares of Amedisys during the second quarter worth $278,000. Finally, Numeric Investors LLC acquired a new position in shares of Amedisys during the second quarter worth $339,000. Institutional investors own 94.97% of the company’s stock.

Amedisys Inc (NASDAQ AMED) opened at $56.16 on Thursday. The stock has a market cap of $1,851.25, a price-to-earnings ratio of 26.10, a P/E/G ratio of 1.14 and a beta of 0.73. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.16. Amedisys Inc has a fifty-two week low of $45.18 and a fifty-two week high of $65.91.

A number of equities analysts have recently commented on the stock. BidaskClub upgraded shares of Amedisys from a “strong sell” rating to a “sell” rating in a report on Wednesday. Zacks Investment Research lowered shares of Amedisys from a “buy” rating to a “hold” rating in a report on Friday, February 2nd. Mizuho restated a “buy” rating and issued a $65.00 target price (up previously from $55.00) on shares of Amedisys in a report on Wednesday, November 8th. Benchmark restated a “hold” rating on shares of Amedisys in a report on Thursday, November 9th. Finally, Craig Hallum restated a “buy” rating and issued a $68.00 target price (up previously from $55.00) on shares of Amedisys in a report on Thursday, November 9th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $60.64.

COPYRIGHT VIOLATION NOTICE: “NorthCoast Asset Management LLC Acquires 11,736 Shares of Amedisys Inc (AMED)” was published by Daily Political and is the property of of Daily Political. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.dailypolitical.com/2018/02/08/northcoast-asset-management-llc-acquires-11736-shares-of-amedisys-inc-amed.html.

Amedisys Profile

Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.

Want to see what other hedge funds are holding AMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amedisys Inc (NASDAQ:AMED).

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.